Success Story: NIW Approval Without RFE for a Medicinal Chemistry Researcher Advancing AI-Enabled Drug Discovery
Client’s Testimonial:
“I am sincerely grateful to everyone who contributed to preparing and filing my petition. Thanks to my attorney for her great efforts. I am highly satisfied with the service I received and would confidently recommend the Chen Immigration Team to other researchers and professionals pursuing an EB-2 NIW petition.”
On August 26th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate and Graduate Student Research Assistant in the Field of Medicinal Chemistry (Approval Notice).
General Field: Medicinal Chemistry
Position at the Time of Case Filing: PhD Candidate and Graduate Student Research Assistant
Country of Origin: Nigeria
State of Residence at the Time of Filing: Michigan
Approval Notice Date: August 26th, 2026
Processing Time: 2 months, 23 days (Premium Processing Upgrade Requested)
Case Summary:
“Finally, given the demand for AI-enabled and biologically validated drug-design frameworks, it is clear there is a need for further advances in these areas. As [Client] has produced highly valuable research in this regard, there is an ongoing demand for his particular expertise.”
This statement is drawn from a recommendation letter emphasizing the client’s broader contributions to the fields of medicinal chemistry, pharmaceutical research, and therapeutic development, highlighting the potential relevance of the client’s work to the development of more efficient research strategies, the identification of promising therapeutic candidates, and the advancement of solutions for significant public health needs.
The client’s work focuses on applying computational methods, medicinal chemistry, molecular design, and biological evaluation to support the discovery and development of potential therapeutic candidates. Holding an M.S. in medicinal chemistry, the client was conducting research at a U.S. university at the time of filing, where he continued contributing to research involving drug discovery, molecular modeling, chemical synthesis, and related biomedical applications.
North America Immigration Law Group (NAILG) prepared the I-140 NIW petition by presenting the client’s work as a proposed endeavor with substantial merit and national importance, not merely as a list of academic activities. The petition showed that the client’s research could contribute to anti-infective drug discovery, antimicrobial resistance mitigation, infectious disease preparedness, and AI-enabled biomedical innovation in the United States.
The client’s record included:
- 8 peer-reviewed journal articles, 2 first-authored abstracts, 1 book
- 113 citations to the client’s published work
- At least 14 completed peer reviews for journals and conferences in medicinal chemistry and related fields
- 2 recommendation letters from experts in the field
The petition explained that the client’s contributions were relevant to multiple areas of biomedical research, including the discovery and optimization of small-molecule and peptide therapeutics, the study of disease-related molecular mechanisms, the development of computational tools for drug design, and the search for new approaches to address infectious diseases and other significant health challenges. His findings provided a foundation that other researchers could use when designing experiments, selecting candidate compounds, interpreting biological activity, and developing more targeted therapeutic strategies.
The petition also explained the strength of the client’s citation record in context. The client had authored 1 paper ranked among the top 1%, 1 paper ranked among the top 10%, and 1 paper ranked among the top 20% most-cited articles for their respective publication years. This evidence helped demonstrate that the client’s work had received recognition beyond ordinary publication and had been meaningfully relied upon by the field.
By combining publication impact, citation context, peer-review service, expert letters, media recognition, current U.S. research activity, and continued plans in medicinal chemistry, NAILG demonstrated that the client was well positioned to advance the proposed endeavor and that his work addressed important U.S. public health needs.
USCIS approved the client’s I-140 NIW petition without an RFE after a premium processing upgrade was requested. This approval supports the client’s continued contributions to medicinal chemistry, AI-enabled drug discovery, anti-infective therapeutic development, and public health preparedness in the United States.